Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study
- PMID: 25355802
- PMCID: PMC4519765
- DOI: 10.1177/1933719114556481
Treatment of uterine myomas by radiofrequency thermal ablation: a 10-year retrospective cohort study
Abstract
Patients' selection criteria, effectiveness, and safety of radiofrequency thermal ablation (RFTA) therapy for uterine myomas (UM) were assessed using a 10-year retrospective cohort study. From July 2001 to July 2011, a total of 1216 patients treated for UM were divided into 2 groups. Group A consisted of 476 premenopause patients, average age 36.5 ± 8.5 years, average number of myomas 1.7 ± 0.9, and average diameter of myomas 4.5 ± 1.5 cm, and group B consisted of 740 menopause patients, average age 48.5 ± 3.5 years, average number of myomas 2.6 ± 1.3, and average diameter of myomas 5.0 ± 2.5 cm. Average follow-up period was 36.5 ± 11.5 months. At 1, 3, 6, 12, and 24 months after RFTA, average diameters of myomas in group A were 3.8, 3.0, 2.7, 2.4, and 2.2 cm, respectively, and 47.7% (227 of 476) of patients had tumor trace at 12 months after RFTA. In group B, the results were 4.7, 3.7, 3.3, 2.3, and 2.3 cm, respectively, and 58.8% (435 of 740) of patients had tumor trace at 12 months after RFTA. Three months after treatment, myoma volumes were significantly reduced in both the groups (P < .01), and group B had higher rate of tumor trace at 12 months after RFTA than group A (P < .05). Clinical symptoms and health-related quality-of-life outcome (HRQL) were significantly improved after RFTA in both groups and the postoperative recurrence rate of UM was significantly higher in group A at 10.7% (51 of 476) than group B at 2.4% (18 of 740; P < .05). Radiofrequency thermal ablation is an excellent minimally invasive treatment for UM smaller than 5.0 cm in diameter.
Keywords: complications; curative effect; minimally invasive treatment; radiofrequency thermal ablation; uterine myoma.
© The Author(s) 2014.
Conflict of interest statement
Figures

Similar articles
-
Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions.J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):1020-1028. doi: 10.1016/j.jmig.2017.05.021. Epub 2017 Jun 27. J Minim Invasive Gynecol. 2017. PMID: 28662989
-
Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas.Eur J Obstet Gynecol Reprod Biol. 2014 Jun;177:38-43. doi: 10.1016/j.ejogrb.2014.03.017. Epub 2014 Mar 29. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24766899
-
Uterine Myoma Position-based Radiofrequency Ablation (UMP-b RFA): 36 months follow-up clinical outcomes.Eur J Obstet Gynecol Reprod Biol. 2023 Feb;281:23-28. doi: 10.1016/j.ejogrb.2022.12.006. Epub 2022 Dec 6. Eur J Obstet Gynecol Reprod Biol. 2023. PMID: 36527825
-
Pregnancy Outcomes After Direct Uterine Myoma Thermal Ablation: Review of the Literature.J Minim Invasive Gynecol. 2017 May-Jun;24(4):538-545. doi: 10.1016/j.jmig.2017.01.009. Epub 2017 Jan 18. J Minim Invasive Gynecol. 2017. PMID: 28109894 Review.
-
Uterine Artery Embolization Compared with High-intensity Focused Ultrasound Ablation for the Treatment of Symptomatic Uterine Myomas: A Systematic Review and Meta-analysis.J Minim Invasive Gynecol. 2021 Feb;28(2):218-227. doi: 10.1016/j.jmig.2020.11.004. Epub 2020 Nov 14. J Minim Invasive Gynecol. 2021. PMID: 33197612
Cited by
-
Hysteroscopic diode laser myolysis: from a case series to literature review of incisionless myolysis techniques for managing heavy menstrual bleeding in premenopausal women.Arch Gynecol Obstet. 2024 Mar;309(3):949-959. doi: 10.1007/s00404-023-07218-y. Epub 2023 Oct 13. Arch Gynecol Obstet. 2024. PMID: 37831177 Free PMC article. Review.
-
Navigating the Landscape of Uterine Fibroid Treatment Using a Novel Scarless Technology (GYIDE): A Case Report.Gynecol Minim Invasive Ther. 2025 Jul 19;14(3):272-276. doi: 10.4103/gmit.GMIT-D-25-00043. eCollection 2025 Jul-Sep. Gynecol Minim Invasive Ther. 2025. PMID: 40786684 Free PMC article.
-
A Prospective Intervention Trial on Tailored Radiofrequency Ablation of Uterine Myomas.Medicina (Kaunas). 2020 Mar 12;56(3):122. doi: 10.3390/medicina56030122. Medicina (Kaunas). 2020. PMID: 32178351 Free PMC article.
-
A Systematic Review of Minimally Invasive Treatments for Uterine Fibroid-Related Bleeding.Reprod Sci. 2022 Oct;29(10):2786-2809. doi: 10.1007/s43032-021-00722-z. Epub 2021 Sep 3. Reprod Sci. 2022. PMID: 34480321
References
-
- Robles R, Aguirre VA, Argueta AI, Guerrero MR. Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up. Int J Gynaecol Obstet. 2013;120 (1):65–69. - PubMed
-
- Cooper K, Lee A, Chien P, Raja E, Timmaraju V, Bhattacharya S. Outcomes following hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG. 2011;118 (10):1171–1179. - PubMed
-
- Sesti F, Ruggeri V, Pietropolli A, Piancatelli R, Piccione E. Thermal balloon ablation versus laparoscopic supracervical hysterectomy for the surgical treatment of heavy menstrual bleeding: a randomized study. J Obstet Gynaecol Res. 2011;37 (11):1650–1657. - PubMed
-
- Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol. 1999;10 (10):1293–1303. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical